IP Library Granted Patent US 11,045,608
Granted Patent B2
US 11,045,608 · App. 16/332,051 · Granted Jun 29, 2021

Injection device with dose indicator mechanism

Inventors: Karl James Hewson (Cambridgeshire, GB); George Bostock (Cambridgeshire, GB); George Robert Michael Savell (Cambridgeshire, GB)
Assignee: Norton Healthcare Limited
A61M5/31551A61M5/20A61M5/31536A61M5/31553A61M5/31583A61M5/24A61M5/3129A61M5/3157A61M5/31511A61M5/31535A61M5/31541A61M5/31593A61M2005/3126A61M2005/3154
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,045,608
App. No.
16/332,051
Granted
Jun 29, 2021
Kind
B2
Abstract

An injection device comprises a housing ( 12 ) having a longitudinal axis. The injection device further comprises a dose selector ( 16 ) capable of setting a dose to be ejected from the injection device and a dose indicator comprising a units wheel ( 18 ) operatively connectable to the dose selector so that rotation of the dose selector about the longitudinal axis also rotates the units wheel, and a tens wheel ( 19 ) selectively engageable with the units wheel so that rotation of the units wheel also rotates the tens wheel. A biasing means biases the dose indicator axially-rearwardly in the housing. An internal surface of the housing is provided with a tens housing feature selectively engageable with the tens wheel to prevent rotation thereof. An internal surface of the housing is provided with a units housing feature capable of moving the units wheel axially-forward against said biasing means such that the units wheel engages and moves the tens wheel axially-forward and free of said tens housing feature so as to allow rotation thereof.

Claims (19)

1. An injection device comprising:

a. a housing having a longitudinal axis;

b. a dose selector capable of setting a dose to be ejected from the injection device;

c. a dose indicator comprising a units wheel operatively connectable to the dose selector so that rotation of the dose selector about the longitudinal axis also rotates the units wheel, and a tens wheel selectively engageable with the units wheel so that rotation of the units wheel also rotates the tens wheel; and

d. a biasing means for biasing the dose indicator axially-rearwardly in the housing,

wherein an internal surface of the housing is provided with a tens housing feature comprising one or more formations selectively engageable with corresponding features on the tens wheel to prevent rotation thereof,

and wherein the internal surface of the housing is provided with a units housing feature capable of moving the units wheel axially-forward against said biasing means such that the units wheel engages and moves the tens wheel axially-forward and free of said tens housing feature so as to allow rotation thereof.

2. The injection device of claim 1 wherein the biasing means is a spring.

3. The injection device of claim 1 wherein the units housing feature comprises a cam surface.

4. The injection device of claim 3 wherein the units wheel comprises an axially-rearwardly-extending formation for engaging said cam surface on the housing.

5. The injection device of claim 1 wherein said units wheel is selectively engageable with said tens wheel by means of one or more teeth on the units wheel engageable with corresponding teeth on said tens wheel.

6. The injection device of claim 5 wherein said formations and/or teeth are regularly spaced.

7. The injection device of claim 5 wherein said formations and/or teeth on the tens wheel are located at a rear end of said tens wheel.

8. The injection device of claim 5 wherein said tens wheel teeth for engaging the units wheel are located radially inwardly of the tens wheel formations for engaging the tens housing feature.

9. The injection device of claim 1 wherein the dose indicator is arranged concentrically about said longitudinal axis.

10. The injection device of claim 1 further comprising a medicament container.

11. The injection device of claim 10 wherein the medicament container comprises a pre-filled syringe or cartridge.

12. The injection device of claim 10 further comprising a medicament contained in the medicament container.

13. The injection device of claim 12 wherein the medicament is selected from the group comprising: antipsychotic substances including risperidone, hormones, antitoxins, substances for the control of pain, immunosuppressives, substances for the control of thrombosis, substances for the control or elimination of infection, peptides, proteins, human insulin or a human insulin analogue or derivative, polysaccharide, DNA, RNA, enzymes, antibodies, oligonucleotide, antiallergics, antihistamines, anti-inflammatories, corticosteroids, disease modifying anti-rheumatic drugs, erythropoietin, or vaccines, for use in the treatment or prevention of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, ulcerative colitis, hormone deficiency, toxicity, pain, thrombosis, infection, diabetes mellitus, diabetic retinopathy, acute coronary syndrome, angina, myocardial infarction, atherosclerosis, cancer, macular degeneration, allergy, hay fever, inflammation, anaemia, or myelodysplasia, or in the expression of protective immunity.

Assignments (1)
CONFIRMATORY ASSIGNMENT Recorded Aug 14, 2019
From: CAMBRIDGE DESIGN PARTNERSHIP
To: NORTON HEALTHCARE LIMITED
Reel/Frame 050716/0364 →
Priority Claims (1)
GB 1615450 · Sep 12, 2016 · national
Continuity (1)
Related Publication 20190262546A1 · Aug 29, 2019